By Alex Constantine
As the Bush-Cheney bund weaves ever closer toward political suicide, it is incumbent upon concerned residents of this great democracy to take stock of reality and not forget the dope - the financial core of black operations waged by the intelligence sector's world-dominating "elite."
The Rockefellers used heroin to quell the Harlem riots in the 1930s, so there are multiple uses for the opiate, but mostly it brings in cash. So wouldn't you know that Bechtel, a recurring name in the history of disgusting corporate scandals to the present day, would have a place in this sordid history.
Drift back in time for a moment to the early 1970s, when the Nixon adminsitration - like Bush's three decades on - teetered uncertainly on the brink of obliteration. The central determinant of Nixon's ultimate downfall was Alexander Butterfield - a former spy stationed in Asia. We'll soon visit more spies with roots in the Far East.
Butterfield, recall, made headlines when he casually announced that the president had tape recorded conversations in the oval office. That was the end of Richard Nixon, who was badly kicked around .. and not one reporter stopped to ponder why a spook in the White House would crucify his boss with this devastating revelation.
Butterfield gave away the store at another key point in history when he spilled the dope beans to Wall Street Journal reporter Jonathan Kwitny, author of The Crimes of Patriots. When asked about Bernie Houghton and other principals at Australia's Nugan Hand Bank, the CIA's cash laundry, Butterfield gave him a few names that broke the bank, so to speak.
Kwitny was referred to General Heine Aderholt, who ran covert operations throughout Asia with John Singlaub, and was in a position to observe the actions of Maurice "Bernie" Houghton at Nugan Hand.
Houghton, it emerged, had been active in the opium trade in the Golden Triangle. Kwitny's investigation led him to dig up a legal claim letter signed by Tom Rahill, an American worker in Dhahrain, Saudi Arabia.
According the this letter, "Mr. Houghton's representatives would visit Aramco construction camps in Saudi Arabia shortly after each monthly payday. We investors would turn over Saudi riyals to be converted at the prevailing dollar exchange rate, and receive a Nugan Hand dollar certificate. ... The monies, we were told, were to be deposited in the Nugan Hand Hong Kong branch for investments in various 'secured' government bonds."
But Aramco wasn't the only company that turned Nugan Hand into a burgeoning financial center.
JWP designs, installs, and supports these technical systems." For more, see: Pollack, Andrew, "JWP Gains Control of Businessland," New York Times, August 6, 1991, and Steinberg, Jacques, "Water Utility of a Thousand Faces," New York Times, November 2, 1991.. )
Employees of Aramco, Beck, Bechtel and University Industries (officials there actually confirmed Kwitny's allegations, to his complete surprise, with the comment, "sounds like you've go quite a story there.") were directed to Bernie Houghton, who talked them into investing in the bank at a promised return of 18%. Houghton only dealt in hard cash, and was seen leaving Bechtel with garbage bags stuffed full of paper money.
When the bank went bust, the employees lost their investments. The scheme made Enron's stock manipulations look like a putting gteen.
U of C political researcher Peter Dale Scott reports on the stunning hypocrisy of George Schultz, who does, however, make a valid point concerning drugs and world terrorism (see http://www.thirdworldtraveler.com/Drug_War/Cocaine_Politics.html):
"President Reagan came to office with a mission: to roll back the frontiers of world communism, especially in the Third World. Almost from the start he singled out Nicaragua as a dangerous base of Soviet bloc operations in the Western Hemisphere. But with the American public's anticommunist sentiments dulled by a decade of détente and memories of Vietnam, how could his administration revive support for combating the Nicaraguan challenge to U.S. power and credibility?
"One answer was to invent a new threat, closely associated with communism and even more frightening to the public: narco-terrorism. The term, rarely well defined by its users, encompasses a variety of phenomena: guerrilla movements that finance themselves by drugs or taxes on drug traffickers, drug syndicates that use terrorist methods to counter the state's law enforcement apparatus, and state-sponsored terrorism associated with drug crimes.' But in the hands of administration officials, the epithet served a more political than analytical purpose: to capitalize on popular fear of terrorists and drug traffickers in order to mobilize support for foreign interventions against leftist regimes. As two private colleagues of Oliver North noted in a prospectus for a propaganda campaign to link the Sandinistas and drugs, "the chance to have a single issue which no one can publicly disagree with is irresistible.
"Administration spokesmen drove the lesson home through sheer repetition. In January 1986, President Reagan said, 'The link between the governments of such Soviet allies as Cuba and Nicaragua and international narcotics trafficking and terrorism is becoming increasingly clear. These twin evils - narcotics trafficking and terrorism - represent the most insidious and dangerous threats to the hemisphere today.' A year and a half earlier, Secretary of State George Shultz decried the 'complicity of communist governments in the drug trade,' which he called 'part of a larger pattern of international lawlessness by communist nations that, as we have seen, also includes support for international terrorism, and other forms of organized violence against legitimate governments.'"
(Today, Shulz is still embedded in the drug trade. For more, see: http://narconews.com/Issue40/article1644.html -
WHO IS CHARLES HILL (OF THE PROJECT FOR THE NEW AMERICAN CENTURY)?
Inside the Iran-contra Cover-Up
At the Core of Iran-Contra and Cover-Up
[From a prior post of mine re Charles Hill]...
... The key notes, taken by CHARLES HILL, Shultz's executive assistant, were nearly verbatim, contemporaneous accounts of Shultz's meetings within the department and Shultz's reports to HILL on meetings the secretary attended elsewhere. The Hill notes and similarly detailed notes by Nicholas Platt, the State Department's executive secretary, provided the OIC with a detailed account of Shultz's knowledge of the Iran arms sales. The most revealing of these notes were not provided to any Iran/contra investigation until 1990 and 1991. The notes show contrary to his early testimony that he was not aware of details of the 1985 arms transfers, Shultz knew that the shipments were planned and that they were delivered. Also in conflict with his congressional testimony was evidence that Shultz was aware of the 1986 shipments.
Independent Counsel concluded that Shultz's early testimony was incorrect, if not false, in significant respects, and misleading, if literally true, in others. When questioned about the discrepancies in 1992, Shultz did not dispute the accuracy of the Hill notes. He told OIC that he believed his testimony was accurate at the time and he insisted that if he had been provided with the notes earlier, he would have testified differently. Independent Counsel declined to prosecute because there was a reasonable doubt that Shultz's testimony was willfully false at the time it was delivered.
Independent Counsel concluded that Hill had willfully withheld relevant notes and prepared false testimony for Shultz in 1987. He declined to prosecute because Hill's claim of authorization to limit the production of his notes and the joint responsibility of Shultz for the resulting misleading testimony, would at trial have raised a reasonable doubt, after Independent Counsel had declined to prosecute Shultz....
1) George Shultz and Gilead,a Leading Bird Flu Vaccine Manufacturer:
2) Shultz, Rusmfeld and Gilead Profit from the Bird Flu Scare:
3) Dr. Tim O'Shea on Bird Flu Profiteering:
1) George Shultz and Gilead, a Leading Bird Flu Vaccine Manufacture...
... One of San Francisco's wealthiest and most prominent couples could choose to have a significant impact on the negotiations. Former Secretary of State George Shultz and his wife, San Francisco Chief of Protocol Charlotte Swig Shultz, own $8,700,000 worth of shares in Gilead. They are Gilead's fourth largest individual shareholders. George Shultz sits on the comparatively small eight-member Board of Directors.
2) Shultz, Rusmfeld and Gilead Profit from the Bird
Gilead Sciences is no small-time biotech startup, either. Helped by the propaganda from its friends in Washington and other high places, today Gilead has a total market capitalization of $ 22 billion. Its boardtoday includes Bechtel Corporation director and former Secretary of State, George P. Shultz. According to Fortune, Shultz turned a neat $7 million profitearlier this year in insider selling of some of his Gilead stock.
Bechtel is right up there with Halliburton in grabbing the lion’s share of Pentagon sweetheart contracts to rebuild Iraq. Most certainly it did not hurt Bechtel’s business that Shultz and Rumsfeld knew each other from their common days on the board of Gilead. The Gilead Sciences board also includes Gordon Moore of Intel, and Viscount Etienne Davignon, the Belgian Count who seems to be involved in everything big and Atlanticist, whether it be Bilderberg meetings or Trilateral Commissions, and now, profiting from the Bird Flu panic.
The Gilead model also suggests a parallel to the Halliburton Corporation, whose former CEO is Vice President Dick Cheney. Cheney’s company has so far gotten billions worth of US construction contracts in Iraq and elsewhere. Is it just a coincidence that Cheney’s closest political friend is Defense Secretary and Avian Flu beneficiary, Donald Rumsfeld? The Defense Secretary is an accomplished hand at getting the government to buy vaccines from companies in which he has a direct financial interest. Recall the scare just following the events of September 11, 2001. One of the terror scenarios discussed widely by the Administration was a possible release of a deadly smallpox attack that would devastate the American population.
In November 2001 the Administration reversed a two decade policy. On the advice of the Pentagon and others in the Administration, the President ordered that the US’ remaining stock of smallpox microbes, stored at the Center for Disease Control in Atlanta, not be destroyed as he world community had been urging, but be kept until new vaccines were developed. The United States and Russian Governments at the time held the only known smallpox microbe stocks known. The disease had long since been eradicated.
The Administration announced at the time it was backing development of a new vaccine for smallpox that could be given the entire population. The major media from Judith Miller in the New York Times, to more widely read papers, carried horror stories. Typical was one from Knight-Ridder which began, ‘When counterterrorism officials compare notes on what keeps them awake at night, the weapon they most fear is not a nuclear bomb or poison gas, but a disease that was wiped off the planet 20 years ago. They worry about smallpox, a lethal, super-contagious virus that, if unleashed, would spread quickly…’
The scare around smallpox and what to do was curiously similar then as it is today against Bird Flu pandemics. Defense Secretary Rumsfeld at that time ordered members of the Armed Forces to be inoculated against smallpox, an inoculation with horrendous side-effects. Rumsfeld’s smallpox package also included ordering Pentagon stockpiling of a drug named Vistide, supposedly to minimize side-effects of smallpox infection should it occur.
The Bush Administration had made repeated attempts to convince the public and above all, the health and
medical profession to go with mass inoculation against smallpox. In 2002 the CDC and certain high Administration officials were calling for pre-emptive smallpox inoculation of broad sectors of the
population against threat of terrorists unleashing the pox. The Government began stockpiling hundreds of millions of smallpox vaccine doses. It also stockpiled Vistide.
With every official statement by members of the Administration, population panic regarding smallpox threats grew. Fear was driving the debate. Yet the reality was that, contrary to what was being said, smallpox was not a highly contagious disease. As Dr. Kuritsky, MD, director of the National Immunization Program and Early Smallpox Response and Planning at the CDC put it, ‘Smallpox has a slow transmission and is not highly contagious.’
Even were someone exposed to a known bio-terrorist attack with smallpox, it would not mean that he would contract smallpox, Kuritsky added. The signs and symptoms of the disease would not occur immediately, and there was time to plan.
Increasingly, experienced US health professionals began going public with the dangers of the side effects from the smallpox immunization itself. These included ‘serious brain and heart diseases, autism, abnormal chromosomal changes, diabetes, various cancers and leukemias, plus demyelination of nerve tissue years after vaccination.’ Many thought it better to run the risk of a bio-terror attack than take the ‘cure.’ The Administration mass vaccination campaign for smallpox was a flop. Yet in the meantime millions of doses of Vistide were produced and sold to the US government, to ‘ease’ the effects of smallpox should such an hypothetical attack materialize. The Pentagon was one of the major purchasers of Vistide at the time.
The smallpox terror scenario fear-mongering reached a peak in the run-up to the February 2003 war in Iraq, with scare stories speculating that Saddam Hussein may have been holding stolen Russian stocks of the smallpox virus ready to unleash an attack on the American public. In his January 2003 State of the Union Address, the President proposed creation of Project BioShield to develop vaccines and drugs against bio-terror attack including anthrax and smallpox.
On July 21, 2004 President Bush signed into law Project BioShield, to provide ‘new tools to improve medical countermeasures protecting Americans against a chemical, biological, radiological, or nuclear (CBRN) attack.’ The fiscal year 2004 appropriation for the Department of Homeland Security included $5.6 billion over 10 years for the purchase of next generation countermeasures against anthrax and smallpox as well as other CBRN agents.
Mr Rumsfeld knew well what he was prescribing for his soldiers. Vistide was also a product of Gilead Sciences, Mr. Rumsfeld’s former company. Rumsfeld was the person who signed off on the decision to give US Troops Vistide. That decision was obviously not made out of benevolence, or concern for the health of the troops on the part of the Defense Secretary, who had been personally involved with the side-efects of Vistide at Gilead since the company first developed it in the late 1990’s as an AIDS treatment. As Rumsfeld well knew, Vistide had some pretty hefty side effects. According to Dr. Christopher J Hogan, MD, Professor at the Department of Emergency Medicine, Medical College of Virginia, complications of Vistide include renal toxicity, neutropenia, fever, anemia, headache, hair loss, uveitis and/or iritis, and abdominal pain. Yet, despite the fact of who is making millions on the fears being stirred over smallpox or Avian Flu, it would be a dangerous diversion to think the end of the story is personal or corporate greed. The alarming aspect to this Tamiflu, Vistide and proposed new legal regimes for the ‘vaccine industry,’ is the fact that it all fits, evidently, into a far larger strategy that the Administration seems to have been developing for some time. During the smallpox scare three years ago, the Administration got Republican Congressmen to insert a paragraph into the Homeland Security bill that would give immunity for liability to drug companies who manufacture smallpox vaccine.
Abolishing the Nuremburg Code on Human Rights in Experimentation
Now the Bush Administration is seeking to vastly expand that drug company immunity, using the climate of fear around Avian Flu.
The President, in his November 1 NIH pandemic speech, proposed completely exempting drug makers from being sued for their products. Explicitly he termed it ‘liability protection for the makers of life-saving vaccine rhetoric, it means drug makers can produce and promote whatever they choose to foist on the public, whether it be Vistide, Tamiflu or Thalidomide, and fear no legal consequences.
One need only think for a minute about the consequences of removing the gains of more than a Century of bitter battles to establish even minimal controls over what drugs can be sold to the public. During the 1960’s in Germany, Dr. Heinrich Mueckter, an infamous Nazi doctor, wanted by the Polish government for hideous experiments using live Typhus on concentration camp inmates, founded a drug company in West Germany where he developed a drug he marketed as a harmless sleeping tablet. His product, Contergan,
was advertised as so harmless that it could be sold over-the-counter and one million Germans used it daily to sleep. He specially marketed his drug for ‘pregnant mothers’ having sleep problems. The results were soon clear in the form of tens of thousands of grotesquely deformed births. The drug he developed contained Thalidomide. At that time, German law left regulation of such drugs to the industry, a kind of self-policing, or to local government.
Or consider the huge scandals surrounding the anti-arthritic drug, VIOXX, which was being used by more than two million people around the world when it was pulled from the market by Merck & Co. last September, after serious studies indicated VIOXX users had a 400% increased risk of heart attack or stroke. Threat of litigation was clearly a major factor leading Merck to pull VIOXX.
Merck & Co. began in Germany in the late 1800’s by selling products including morphine, codeine, quinine and strychnine as ‘medications.’ There were no regulations on drug makers then. The German aspirin inventor, Bayer Company, in 1898 sold heroin labelled as a ‘superior cough suppressant.’ It probably was, but they also didn’t speak of side effects in those days. This was before many such scandals and serious consequences on the public forced governments to begin regulating what was sold as drugs.
In 1962, in response to the Thalidomide scandals, Senator Estes Kefauver drafted and got passed the Kefauver-Harris Drug Amendments of 1962, tightening drug safety requirements and requiring pharmaceutical makers, or as George Bush prefers to call it, ‘the vaccine industry,’ to prove a given drug is effective before it can be sold to the public. Drugs were required to be registered with the US Food and Drug Administration, and the FDA was given ‘explicit authority to require compliance with good manufacturing practices.’ Safety and purity standards were defined. It also required drug makers explicitly state risks in their products.
In 1948 the member countries of the United Nations adopted the so-called Nuremburg Code following the military trial in Nuremburg Germany in 1946 of 23 Nazi doctors for crimes against humanity and experimentation with drugs and viruses on human subjects. It was recognized as international common law guiding medical research. With the grant of legal immunity from lawsuits for effects of their drugs, pharmaceutical companies would succeed in rolling back not only the Nuremburg Code but also more than a Century of bitterly-fought gains in public safety in the regulation of drug manufacturing and promotion. In promoting drug industry immunity from legal damage suits, the President claims he is ‘breaking downbarriers to vaccine production.’ In reality he is taking steps to create an environment which not even the Nazi doctors and drug companies during the Third Reich enjoyed—they had to be secretive about their actions. This is a very alarming precedent should it become law. The real question to ask is what could be so important to compel the President of the United States to put his own population at risk in such an unfettered drug environment?
That there exists a virulent viral strain affecting birds especially in parts of Vietnam and China is not the issue at hand here. Rather it is the politicization of such a condition to introduce a wholly other agenda, one whose ultimate consequences on human life and well-being are potentially far more damaging than any conceived damage from H5N1 or other virus strains.
3) Tim O'Shea on Bird Flu Profiteering
As with the marketing of smallpox vaccine in 2002  and the marketing of SARS in 2003 , it's a fairly safe bet the threat of avian flu will disappear as soon as the money has been spent stockpiling the drugs and vaccines.
That's the usual pattern. Count on it. The two remedies for avian flu being hawked daily from every quarter are Tamiflu and a new flu vaccine. Let's look behind the scenes a little and see whose money is on the line here, and who would benefit from the sale of enough of these drugs for the entire world. First Tamiflu.
In 1996 two drug giants - Hoffman LaRoche and Gilead Sciences agreed to split the world between them.
Gilead had invented a new type of flu drugs called neuraminidase inhibitors, which included Tamiflu. 
The deal was that LaRoche could research and market the drug worldwide, and Gilead would be paid residuals. Forever. Gilead Sciences, located in Foster City, California, joined the NASDAQ 100 in 2001. Its 2004 revenues were only $1.3 billion,  but that's about to change. From 1997 until the time he was sworn in as Secretary of Defense in 2001, guess who had been Chairman of the Board of Gilead Sciences. Donald Rumsfeld. Don't believe it? Good. Look at the Dept of Defense website. At present Rumsfeld continues to receive stock and benefits from Gilead, and is a major shareholder. 
Another member of Gilead's Board of Directors is George Schultz, whom you may remember as Secretary of Treasury under Nixon.  One of the financial directors of the Vietnam war, Schultz is still technically alive. So. How does the financial future of Gilead appear, with sales of Tamiflu? Best estimates at present: between $1 - 1.8 billion. And that's just for the US market. [12, 13] Such a figure would double Gilead's total income for 2004. Just for one drug.
Taking the global market into consideration, sales revenue from Tamiflu is virtually "unlimited."  A sacred word for investors. The US Senate approved $3.9 billion for Tamiflu purchase back in Sept 2005 with virtually no discussion.  And Gilead smiled. But the best news for investors is that the Tamiflu windfall will be around for a long time. Again, from the WHO FAQ sheet: "At present manufacturing capacity, which has recently quadrupled, it will take a decade to produce enough oseltamivir to treat 20% of the world's population."
 Oseltamivir - that's Tamiflu.
Keep asking yourself: who would benefit from the threat of pandemic?